More on RNAC

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-276.0% Growth)
- Ratings (8.8 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cartesian Therapeutics (NQ:RNAC)
Delayed: 9.63 -0.25 (2.53%)
Prev. Close $9.88  
Open$10.10 
52 Wk High$ 
52 Wk Low$ 
Day High$10.39 
Day Low$9.45 
P/E N/A  
EPS$ 
Volume354,814 


Jun 17, 2026 04:01 PM Form 8-K Cartesian Therapeutics, For: Jun 12
Jun 12, 2026 04:05 PM Cartesian Therapeutics Announces New Employment Inducement Grant
Jun 9, 2026 04:15 PM Form 144 Cartesian Therapeutics, Filed by: Miljkovic Milos
Jun 9, 2026 07:17 AM Form 8-K Cartesian Therapeutics, For: Jun 09
Jun 9, 2026 07:01 AM Cartesian Therapeutics partners with WestGene for in vivo CAR-T development
Jun 9, 2026 07:00 AM Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases
Jun 2, 2026 04:07 PM Form 144 Cartesian Therapeutics, Filed by: Miljkovic Milos
May 26, 2026 10:48 AM Mizuho on Cartesian Therapeutics (RNAC): 'We believe the potential of Descartes-08 remains underappreciated'
May 26, 2026 07:09 AM Form 8-K Cartesian Therapeutics, For: May 22
May 26, 2026 07:00 AM Cartesian Therapeutics secures $150 million credit facility from K2 HealthVentures
View All Articles

Entities mentioned with RNAC

View All Entities